Gastric microbial community profiling reveals a dysbiotic cancer-associated microbiota

Gut

Volumn 67, Issue 2, 2018, Pages 226-236

  Ferreira, Rui M ^a,b   Pereira Marques, Joana ^a,b   Pinto Ribeiro, Ines ^a,b,c   Costa, Jose L ^a,b,c   Carneiro, Fatima ^a,b,c,d   MacHado, Jose C ^a,b,c   Figueiredo, Ceu ^a,b,c  

^a UNIVERSITY OF PORTO   (Portugal)

^b UNIVERSITY OF PORTO   (Portugal)

^c University of Porto   (Portugal)

^d Universidade do Porto   (Portugal)

Author keywords

bacterial infection; gastric carcinoma; gastritis; Helicobacter pylori

Indexed keywords

RNA 16S;

ADULT; ARTICLE; CHRONIC GASTRITIS; COMMENSAL; DYSBIOSIS; EFFECT SIZE; FEMALE; GASTRIC MICROBIOTA; GEOGRAPHY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MICROBIAL COMMUNITY; MICROBIAL DIVERSITY; MICROFLORA; NEXT GENERATION SEQUENCING; NONHUMAN; PRIORITY JOURNAL; QUALITY CONTROL; REAL TIME POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDY; STOMACH CARCINOMA; TAXONOMY; AGED; BACTERIUM; CARCINOMA; CHRONIC DISEASE; GASTRITIS; GENETICS; HELICOBACTER INFECTION; HELICOBACTER PYLORI; INTESTINE FLORA; METABOLISM; MICROBIOLOGY; MIDDLE AGED; NITROSATION; STOMACH; STOMACH MUCOSA; STOMACH TUMOR;

ADULT; AGED; BACTERIA; CARCINOMA; CHRONIC DISEASE; DYSBIOSIS; FEMALE; GASTRIC MUCOSA; GASTRITIS; GASTROINTESTINAL MICROBIOME; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; NITROSATION; RETROSPECTIVE STUDIES; RNA, RIBOSOMAL, 16S; STOMACH; STOMACH NEOPLASMS;

EID: 85043251326     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gutjnl-2017-314205     Document Type: Article

References (46)

1. Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 2015;136:E359-6.
2. Correa P. Human gastric carcinogenesis: a multistep and multifactorial process-first American cancer society award lecture on cancer epidemiology and prevention. Cancer Res 1992;52:6735-40.
3. Plottel CS, Blaser MJ. Microbiome and malignancy. Cell Host Microbe 2011;10:324-35.
4. E l-Omar EM, Oien K, El-Nujumi A, et al. Helicobacter pylori infection and chronic gastric acid hyposecretion. Gastroenterology 1997;113:15-24.
5. Fukase K, Kato M, Kikuchi S, et al. Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial. Lancet 2008;372:392-7.
6. Ma JL, Zhang L, Brown LM, et al. Fifteen-year effects of Helicobacter pylori, garlic, and vitamin treatments on gastric cancer incidence and mortality. J Natl Cancer Inst 2012;104:488-92.
7. Wong BC, Lam SK, Wong WM, et al. Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial. JAMA 2004;291:187-94.
8. Stockbruegger RW. Bacterial overgrowth as a consequence of reduced gastric acidity. Scand J Gastroenterol Suppl 1985;111:7-15.
9. L each SA, Thompson M, Hill M. Bacterially catalysed N-nitrosation reactions and their relative importance in the human stomach. Carcinogenesis 1987;8:1907-12.
10. L ofgren JL, Whary MT, Ge Z, et al. Lack of commensal flora in helicobacter pyloriinfected INS-GAS mice reduces gastritis and delays intraepithelial neoplasia. Gastroenterol 2011;140:210-20.
11. L ertpiriyapong K, Whary MT, Muthupalani S, et al. Gastric colonisation with a restricted commensal microbiota replicates the promotion of neoplastic lesions by diverse intestinal microbiota in the Helicobacter pylori INS-GAS mouse model of gastric carcinogenesis. Gut 2014;63:54-63.
12. Bik EM, Eckburg PB, Gill SR, et al. Molecular analysis of the bacterial microbiota in the human stomach. Proc Natl Acad Sci U S A 2006;103:732-7.
13. Maldonado-Contreras A, Goldfarb KC, Godoy-Vitorino F, et al. Structure of the human gastric bacterial community in relation to Helicobacter pylori status. Isme J 2011;5:574-9.
14. Delgado S, Cabrera-Rubio R, Mira A, et al. Microbiological survey of the human gastric ecosystem using culturing and pyrosequencing methods. Microb Ecol 2013;65:763-72.
15. Aviles-Jimenez F, Vazquez-Jimenez F, Medrano-Guzman R, et al. Stomach microbiota composition varies between patients with non-atrophic gastritis and patients with intestinal type of gastric cancer. Sci Rep 2014;4:4202.
16. Dicksved J, Lindberg M, Rosenquist M, et al. Molecular characterization of the stomach microbiota in patients with gastric cancer and in controls. J Med Microbiol 2009;58:509-16.
17. Figueiredo C, Machado JC, Pharoah P, et al. Helicobacter pylori and interleukin 1 genotyping: an opportunity to identify high-risk individuals for gastric carcinoma. J Natl Cancer Inst 2002;94:1680-7.
18. Machado JC, Figueiredo C, Canedo P, et al. A proinflammatory genetic profile increases the risk for chronic atrophic gastritis and gastric carcinoma. Gastroenterol 2003;125:364-71.
19. Yu G, Torres J, Hu N, et al. Molecular characterization of the human stomach microbiota in gastric cancer patients. Front Cell Infect Microbiol 2017;7:302.
20. Andersson AF, Lindberg M, Jakobsson H, et al. Comparative analysis of human gut microbiota by barcoded pyrosequencing. PLoS One 2008;3:e2836.
21. Walters WA, Caporaso JG, Lauber CL, et al. PrimerProspector: de novo design and taxonomic analysis of barcoded polymerase chain reaction primers. Bioinformatics 2011;27:1159-61.
22. E dgar RC. UPARSE: highly accurate OTU sequences from microbial amplicon reads. Nat Methods 2013;10:996-8.
23. E dgar RC. Search and clustering orders of magnitude faster than BLAST. Bioinformatics 2010;26:2460-1.
24. Caporaso JG, Kuczynski J, Stombaugh J, et al. QIIME allows analysis of highthroughput community sequencing data. Nat Methods 2010;7:335-6.
25. DeSantis TZ, Hugenholtz P, Larsen N, et al. Greengenes, a chimera-checked 16S rRNA gene database and workbench compatible with ARB. Appl Environ Microbiol 2006;72:5069-72.
26. Anderson MJ. A new method for non-parametric multivariate analysis of variance. Austral Ecology 2001;26:32-46.
27. Segata N, Izard J, Waldron L, et al. Metagenomic biomarker discovery and explanation. Genome Biol 2011;12:R60.
28. L angille MG, Zaneveld J, Caporaso JG, et al. Predictive functional profiling of microbial communities using 16S rRNA marker gene sequences. Nat Biotechnol 2013;31:814-21.
29. Parks DH, Tyson GW, Hugenholtz P, et al. STAMP: statistical analysis of taxonomic and functional profiles. Bioinformatics 2014;30:3123-4.
30. White JR, Nagarajan N, Pop M. Statistical methods for detecting differentially abundant features in clinical metagenomic samples. PLoS Comput Biol 2009;5:e1000352.
31. Gevers D, Kugathasan S, Denson LA, et al. The treatment-naive microbiome in newonset Crohn's disease. Cell Host Microbe 2014;15:382-92.
32. Coker OO, Dai Z, Nie Y, et al. Mucosal microbiome dysbiosis in gastric carcinogenesis. Gut 2017. doi: 10. 1136/gutjnl-2017-314281. [Epub ahead of print 1 Aug 2017].
33. L epage P, Häsler R, Spehlmann ME, et al. Twin study indicates loss of interaction between microbiota and mucosa of patients with ulcerative colitis. Gastroenterol 2011;141:227-36.
34. Ahn J, Sinha R, Pei Z, et al. Human gut microbiome and risk for colorectal cancer. J Natl Cancer Inst 2013;105:1907-11.
35. Thorens J, Froehlich F, Schwizer W, et al. Bacterial overgrowth during treatment with omeprazole compared with cimetidine: a prospective randomised double blind study. Gut 1996;39:54-9.
36. Schulz C, Schütte K, Koch N, et al. The active bacterial assemblages of the upper GI tract in individuals with and without Helicobacter infection. Gut 2016. doi: 10. 1136/ gutjnl-2016-312904. [Epub ahead of print 5 Dec 2016].
37. L i XX, Wong GL, To KF, et al. Bacterial microbiota profiling in gastritis without Helicobacter pylori infection or non-steroidal anti-inflammatory drug use. PLoS One 2009;4:e7985.
38. Yang I, Woltemate S, Piazuelo MB, et al. Different gastric microbiota compositions in two human populations with high and low gastric cancer risk in Colombia. Sci Rep 2016;6:18594.
39. Kelly CP, LaMont JT. Clostridium difficile--more difficult than ever. N Engl J Med 2008;359:1932-40.
40. Rajili-Stojanovi M, de Vos WM. The first 1000 cultured species of the human gastrointestinal microbiota. FEMS Microbiol Rev 2014;38:996-1047.
41. Jiao YS, Yan H, Ji ZJ, et al. Phyllobacterium sophorae sp. nov., a symbiotic bacterium isolated from root nodules of Sophora flavescens. Int J Syst Evol Microbiol 2015;65:399-406.
42. Forsythe SJ, Dolby JM, Webster AD, et al. Nitrate-and nitrite-reducing bacteria in the achlorhydric stomach. J Med Microbiol 1988;25:253-9.
43. Sjöstedt S, Heimdahl A, Kager L, et al. Microbial colonization of the oropharynx, esophagus and stomach in patients with gastric diseases. Eur J Clin Microbiol 1985;4:49-51.
44. Mowat C, Williams C, Gillen D, et al. Omeprazole, Helicobacter pylori status, and alterations in the intragastric milieu facilitating bacterial N-nitrosation. Gastroenterol 2000;119:339-47.
45. Barthold SW, Jonas AM. Morphogenesis of early 1, 2-dimethylhydrazine-induced lesions and latent period reduction of colon carcinogenesis in mice by a variant of Citrobacter freundii. Cancer Res 1977;37:4352-60.
46. Newman JV, Kosaka T, Sheppard BJ, et al. Bacterial infection promotes colon tumorigenesis in Apc(Min/+) mice. J Infect Dis 2001;184:227-30.